Proposal for water quality standards for PFOA RIVM proposes water quality standards for perfluoro octanoic acid (PFOA). PFOA is a man-made chemical that is used to protect surfaces.
RIVM to lead innovative European efforts on health promoting health systems How can we strengthen and support health promoting approaches within the broader health and social care system? And how can we best include other sectors in this process?
Policies on magnetic fields of power lines in five countries reviewed Policies on magnetic fields from power lines in the Netherlands, Belgium, France, Germany and the United Kingdom are based on different considerations.
Practical training on Water Quality Monitoring in Tajikistan For the WHO-EURO project “Small and safe: scaling-up water safety planning and effective water quality monitoring in rural Tajikistan”, Harold van den Berg (RIVM) visited the five Sanitary Epidemio
Water Safety Planning and Water Quality Monitoring Ethiopia From 20–26 August 2017, Harold van den Berg (RIVM) and Bettina Rickert (Umweltbundesamt, Germany) visited Ethiopia for the continuation of the project Source to Tap and Back.
Risk assessment of nanoparticles in the environment Nanotechnology is being used for many everyday life products such as in medicine, deodorants, sunscreens or socks.
What is on our plate? Safe, healthy and sustainable diets in the Netherlands Last January RIVM published a report with facts and figures about the Dutch dietary pattern and an analysis where sustainable, healthy and safe food can strengthen each other.
Building blocks for a definition of microplastics The Dutch National Institute for Public Health and the Environment, RIVM has described building blocks for a definition of microplastics.
Jacco Wallinga appointed extraordinary Professor at LUMC From 1 September, Jacco Wallinga will hold the chair in Mathematical Modelling of Infectious Diseases at the department of Medical Statistics and Bio-informatics of the Leiden University Medical Ce
Little incentive from pharmaceutical legislation to promote alternatives to animal testing Current pharmaceutical legislation does not impose any legal constraints on the use of alternatives to animal testing, but neither does it actively encourage the use of these alternatives.